Skip to main content

How effective is Lynparza (olaparib)?

Medically reviewed by Leigh Ann Anderson, PharmD. Last updated on July 5, 2024.

Official Answer by Drugs.com

Key Points

Lynparza (olaparib) is an oral medicine approved for the treatment of advanced ovarian cancer, fallopian tube cancer, and peritoneal cancer; breast cancer; pancreatic cancer; and prostate cancer that is metastatic (has spread in the body). It is also approved to as an adjunct to treat HER2-negative, high-risk early breast cancer with BRCA mutations.

How effective is Lynparza for ovarian cancer?

In advanced ovarian cancer, Lynparza can help keep ovarian cancer from growing or returning after you have had a response to platinum-based chemotherapy that you received before Lynparza.

Lynparza has also shown positive results in other studies in women with advanced ovarian cancer when used with bevacizumab (Avastin). Talk to your doctor about Lynparza and how it may work for you.

How effective is Lynparza for breast cancer?

HER2-negative, metastatic breast cancer with BRCA mutations

Lynparza is used to help shrink or slow the growth inherited of BRCA-mutated, human epidermal growth factor receptor 2 (HER2)-negative breast cancer that has spread to other parts of the body (metastatic).

You should have already received chemotherapy medicines, either before or after your cancer has spread. If you have hormone receptor (HR)-positive breast cancer, you should have been treated with hormonal therapy.

HER2-negative, high-risk early breast cancer with BRCA mutations

Related questions

How effective is Lynparza for pancreatic cancer?

Lynparza can be used as a maintenance treatment for patients with a form of pancreatic cancer that has abnormal genes (gBRCA mutations). It can be used when the cancer has not progressed after at least 16 weeks of first-line platinum-based chemotherapy.

How effective is Lynparza for prostate cancer?

Lynparza is also used to treat metastatic prostate cancer with certain inherited or acquired abnormal genes (HRR gene mutations) which no longer responds to previous treatments or surgery.

What are the most common side effects with Lynparza?

Lynparza is also associated with other common or serious side effects and warnings. Review the product labeling to learn more and speak with your health care provider before treatment begins.

Learn more: Drugs.com Lynparza Patient Information

This is not all the information you need to know about Lynparza (olaparib) for safe and effective use and does not take the place of talking to your doctor about your treatment. Review the full Lynparza information here, and discuss this information and any questions you have with your doctor or other health care provider.

References

Read next

What is FOLFIRINOX regimen​ and how is it used?

FOLFIRINOX is a four-drug chemotherapy regimen that contains folinic acid (leucovorin), fluorouracil (5-FU), irinotecan, and oxaliplatin. It is primarily used to treat advanced pancreatic cancer, including metastatic and locally advanced (inoperable) cases.

Continue reading

How does erlotinib work (mechanism of action)?

Erlotinib works by blocking the epidermal growth factor receptor (EGFR), a protein on cells that encourages cancer cell growth. Continue reading

Does Sutent shrink tumors?

Five times as many people with renal cell carcinoma (RCC) saw their tumors shrink with Sutent compared with those who were taking interferon α (IFNα). Studies also reported that, on average, people treated with Sutent lived more than twice the number of months without progression compared to those taking IFNα. Overall, clinical trials have proven that Sutent is more effective than IFNα, but some people may not tolerate it well, and it has a black box warning for severe liver toxicity. Sutent is not a cure, and it may not be effective for everybody. Continue reading

See also:

Related medical questions

Drug information

Related support groups